Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP312668.RA_mvH4kWJM1lA8uL1Rdi5-qukdTH8n4bHVJudrIfEgy8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP312668.RA_mvH4kWJM1lA8uL1Rdi5-qukdTH8n4bHVJudrIfEgy8130_assertion type Assertion NP312668.RA_mvH4kWJM1lA8uL1Rdi5-qukdTH8n4bHVJudrIfEgy8130_head.
- NP312668.RA_mvH4kWJM1lA8uL1Rdi5-qukdTH8n4bHVJudrIfEgy8130_assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP312668.RA_mvH4kWJM1lA8uL1Rdi5-qukdTH8n4bHVJudrIfEgy8130_provenance.
- NP312668.RA_mvH4kWJM1lA8uL1Rdi5-qukdTH8n4bHVJudrIfEgy8130_assertion evidence source_evidence_literature NP312668.RA_mvH4kWJM1lA8uL1Rdi5-qukdTH8n4bHVJudrIfEgy8130_provenance.
- NP312668.RA_mvH4kWJM1lA8uL1Rdi5-qukdTH8n4bHVJudrIfEgy8130_assertion SIO_000772 11877595 NP312668.RA_mvH4kWJM1lA8uL1Rdi5-qukdTH8n4bHVJudrIfEgy8130_provenance.
- NP312668.RA_mvH4kWJM1lA8uL1Rdi5-qukdTH8n4bHVJudrIfEgy8130_assertion wasDerivedFrom befree-20140225 NP312668.RA_mvH4kWJM1lA8uL1Rdi5-qukdTH8n4bHVJudrIfEgy8130_provenance.
- NP312668.RA_mvH4kWJM1lA8uL1Rdi5-qukdTH8n4bHVJudrIfEgy8130_assertion wasGeneratedBy ECO_0000203 NP312668.RA_mvH4kWJM1lA8uL1Rdi5-qukdTH8n4bHVJudrIfEgy8130_provenance.